Edgewell Personal Care (EPC) Stock
Company Profile
Price: $34.39
Market Cap: $1.70B
Exchange: NYSE
CEO: Mr. Rod R. Little
Sector: Consumer Defensive
Industry: Household & Personal Products
Employees: 6.80K
Headquarters: Shelton, CT
Website: Edgewell Personal Care
Business Summary
Edgewell Personal Care Company, together with its subsidiaries, manufactures and markets personal care products worldwide. It operates through three segments: Wet shave, Sun and Skin care, and Feminine care. The Wet Shave segment provides razor systems, such as razor handles and refillable blades, and disposable shave products for men and women under the Schick, Wilkinson Sword, Edge, Skintimate, Shave Guard, and Personna brands. The Sun and Skin Care segment provides general protection, sport, kids, baby, tanning and after sun products under the Banana Boat and Hawaiian Tropic brands, as well as antibacterial hand wipes, alcohol sanitizing wipes, and hand sanitizer gels under the Wet Ones brand; and skin care products for men under the Bulldog and Jack Black brands, and skin care and grooming products under the Cremo brand. The Feminine Care segment provides tampons under the Playtex Gentle Glide 360°, Playtex Sport, Playtex and o.b. brands; and markets pads and liners under the Stayfree and Carefree brands. The company was formerly known as Energizer Holdings, Inc. and changed its name to Edgewell Personal Care Company in June 2015. Edgewell Personal Care Company was founded in 1772 and is headquartered in Shelton, Connecticut.
Edgewell Personal Care Chart
Edgewell Personal Care News
Edgewell Personal Care Appoints Jessica Spence as President of North America Business
SHELTON, Conn. , Oct. 2, 2024 /PRNewswire/ -- Edgewell Personal Care Company (NYSE: EPC) is pleased to announce the appointment of Jessica Spence as President of its North America business, effective October 24, 2024.
-
prnewswire.com
2024-10-02
Edgewell Personal Care Receives U.S. EPA 2024 SmartWay Excellence Award
Award Recipients are Top Environmental Performers and Leaders for Freight Supply Chain Efficiency SHELTON, Conn., Sept. 25, 2024 /PRNewswire/ -- Edgewell Personal Care Company (NYSE: EPC) has received the SmartWay® Excellence Award from the U.S. Environmental Protection Agency, as a true industry leader in freight and supply chain environmental performance, and energy efficiency.
-
prnewswire.com
2024-09-25
Clean Vision Corporation Signs EPC Agreement with UPS Industrial Services for West Virginia Facility
LOS ANGELES, CA / ACCESSWIRE / September 23, 2024 / Clean Vision Corporation (OTCQB:CLNV) ("Clean Vision" or the "Company"), an emerging leader in innovative plastic recycling and clean fuel development, is proud to announce that its wholly owned subsidiary, Clean-Seas West Virginia, Inc. ("Clean-Seas West Virginia"), has signed an agreement with UPS Industrial Services, LLC ("UPSIS") for the engineering, procurement, and construction ("EPC") of its plastic conversion facility in Quincy, West Virginia. The project is scheduled to commence in the fourth quarter of 2024, with full operations expected by August 2025.
-
accesswire.com
2024-09-23
Despite Weak Spots, Edgewell Personal Care Company Is An Attractive Opportunity
Edgewell Personal Care Company remains a 'buy' due to its attractive valuation, despite mixed financial results and a recent 5.8% stock pullback. The company's revenue dip was primarily due to foreign currency fluctuations, with organic revenue actually increasing by $4 million year over year. Higher compensation and legal costs impacted net income, but gross profit margin improved from 43.1% to 44.3%, driven by higher prices and revenue management.
-
seekingalpha.com
2024-09-14
Is Edgewell Personal Care (EPC) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
-
zacks.com
2024-09-12
Shifting Targets: Are These Two Stocks A Better Bet Than TGT?
If you are a Target (NYSE: TGT) stock investor and took advantage of the stock's reasonably strong run-up over the past month, it may be time to look elsewhere. As of this moment, we find Edgewell Personal Care (NYSE: EPC) - a consumer products company that sells shaving, sun care, and feminine care products - and AerCap Holdings (NYSE: AER)- an aviation leasing company - to be better bets than Target stock.
-
forbes.com
2024-08-29
Edgewell Personal Care to Webcast Fireside Chat at the 2024 Barclays Global Consumer Staples Conference
SHELTON, Conn. , Aug. 28, 2024 /PRNewswire/ -- Edgewell Personal Care Company (NYSE: EPC) today announced that it will participate in a fireside chat at the Barclays 2024 Global Consumer Staples Conference in Boston on Wednesday September 4, 2024, at 3:45 P.M.
-
prnewswire.com
2024-08-28
Edgewell Personal Care Earnings
This section highlight's Edgewell Personal Care's earnings, including earnings call transcripts, earnings surprises, and key dates.
Edgewell Personal Care Earnings Call Transcripts
Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
---|---|---|---|---|---|
Read Transcript | Q3 | 2024 | 2024-08-06 | $1.01 | $1.22 |
Read Transcript | Q2 | 2024 | 2024-05-08 | $0.72 | $0.88 |
Read Transcript | Q1 | 2024 | 2024-02-07 | $0.06 | $0.24 |
Read Transcript | Q4 | 2023 | 2023-11-09 | $0.64 | $0.72 |
Read Transcript | Q3 | 2023 | 2023-08-07 | N/A | N/A |
Read Transcript | Q2 | 2023 | 2023-05-09 | $0.35 | $0.56 |
Read Transcript | Q1 | 2023 | 2023-02-08 | $0.21 | $0.31 |
Read Transcript | Q4 | 2022 | 2022-11-10 | $0.76 | $0.79 |
Read Transcript | Q3 | 2022 | 2022-08-06 | N/A | N/A |
Read Transcript | Q2 | 2022 | 2022-05-14 | N/A | N/A |
Read Transcript | Q1 | 2022 | 2022-02-08 | $0.42 | $0.42 |
Edgewell Personal Care Earnings Dates
When is the next earnings date for EPC?
Date: 2024-11-14Status: Unconfirmed
Time of Day: Before Market
Estimated EPS: $0.67
When was the last earnings date for EPC?
Date: 2024-08-06Fiscal Date Ending: 2024-06-30
EPS: $1.22
Estimated EPS: $1.01
Revenue: $647.80M
Estimated Revenue: $550.53M
Upcoming EPC Earnings
Date | Estimated EPS | Time of Day | Status |
---|---|---|---|
2024-11-14 | $0.67 | Before Market | Unconfirmed |
2025-02-05 | N/A | Before Market | Unconfirmed |
2025-05-06 | N/A | Before Market | Unconfirmed |
2025-08-04 | N/A | Before Market | Unconfirmed |
Financial Statements
This section provides financial statements for Edgewell Personal Careincluding income statements, balance sheets, and cash flow statements, both annually and quarterly.
Annual Income Statement
Breakdown | 2019-09-30 | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 |
---|---|---|---|---|---|
Revenue | $2.14B | $1.95B | $2.09B | $2.17B | $2.25B |
Cost of Revenue | $1.17B | $1.07B | $1.14B | $1.29B | $1.31B |
Gross Profit | $966.60M | $880.90M | $950.10M | $879.40M | $938.40M |
Gross Profit Ratio | 45.15% | 45.18% | 45.52% | 40.49% | 41.68% |
Research and Development Expenses | $53.50M | $55.30M | $57.80M | $55.50M | $58.50M |
General and Administrative Expenses | $372.00M | $408.80M | $391.20M | $389.10M | $409.60M |
Selling and Marketing Expenses | $250.90M | $216.20M | $241.50M | $238.30M | $229.10M |
Selling General and Administrative Expenses | $622.90M | $625.00M | $632.70M | $627.40M | $638.70M |
Other Expenses | $-1.50M | $-5.40M | $1.20M | $13.20M | $-800.00K |
Operating Expenses | $676.40M | $680.30M | $690.50M | $682.90M | $697.20M |
Cost and Expenses | $1.85B | $1.75B | $1.83B | $1.98B | $2.01B |
Interest Income | $62.60M | $61.20M | $67.90M | $71.40M | $76.40M |
Interest Expense | $62.60M | $61.20M | $67.90M | $71.40M | $78.50M |
Depreciation and Amortization | $91.90M | $88.80M | $87.10M | $89.90M | $91.40M |
EBITDA | $382.50M | $284.00M | $347.90M | $299.60M | $331.80M |
EBITDA Ratio | 17.87% | 14.57% | 16.67% | 13.80% | 14.74% |
Operating Income | $288.70M | $195.20M | $238.80M | $181.20M | $224.60M |
Operating Income Ratio | 13.48% | 10.01% | 11.44% | 8.34% | 9.98% |
Total Other Income Expenses Net | $-658.00M | $-107.90M | $-92.80M | $-58.20M | $-17.40M |
Income Before Tax | $-369.30M | $87.30M | $146.00M | $123.00M | $145.30M |
Income Before Tax Ratio | -17.25% | 4.48% | 6.99% | 5.66% | 6.45% |
Income Tax Expense | $-16.40M | $19.70M | $29.00M | $24.40M | $32.40M |
Net Income | $-352.90M | $67.60M | $117.80M | $99.50M | $114.70M |
Net Income Ratio | -16.48% | 3.47% | 5.64% | 4.58% | 5.09% |
EPS | $-6.52 | $1.24 | $2.15 | $1.87 | $2.24 |
EPS Diluted | $-6.52 | $1.24 | $2.12 | $1.86 | $2.21 |
Weighted Average Shares Outstanding | 54.10M | 54.30M | 54.40M | 53.10M | 51.20M |
Weighted Average Shares Outstanding Diluted | 54.10M | 54.60M | 55.20M | 53.60M | 51.80M |
SEC Filing | Source | Source | Source | Source | Source |
Quarterly Income Statement
Breakdown | 2019-09-30 | 2019-12-31 | 2020-03-31 | 2020-06-30 | 2020-09-30 | 2020-12-31 | 2021-03-31 | 2021-06-30 | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $528.00M | $454.00M | $523.00M | $483.90M | $488.80M | $451.10M | $519.30M | $573.70M | $543.20M | $463.30M | $547.70M | $623.80M | $536.90M | $469.10M | $598.40M | $650.00M | $534.10M | $488.90M | $599.40M | $647.80M |
Cost of Revenue | $298.00M | $260.90M | $280.00M | $261.20M | $266.70M | $257.80M | $277.60M | $303.40M | $298.40M | $273.40M | $317.60M | $383.20M | $318.10M | $280.10M | $356.70M | $370.30M | $306.10M | $291.20M | $341.30M | $360.70M |
Gross Profit | $230.00M | $193.10M | $243.00M | $222.70M | $222.10M | $193.30M | $241.70M | $270.30M | $244.80M | $189.90M | $230.10M | $240.60M | $218.80M | $189.00M | $241.70M | $279.70M | $228.00M | $197.70M | $258.10M | $287.10M |
Gross Profit Ratio | 43.56% | 42.53% | 46.46% | 46.02% | 45.44% | 42.85% | 46.54% | 47.12% | 45.07% | 40.99% | 42.01% | 38.57% | 40.75% | 40.29% | 40.39% | 43.03% | 42.69% | 40.44% | 43.06% | 44.32% |
Research and Development Expenses | $14.00M | $13.80M | $13.90M | $12.40M | $15.20M | $13.70M | $14.30M | $14.60M | $15.20M | $12.80M | $13.70M | $13.60M | $15.40M | $13.40M | $14.40M | $14.80M | $15.90M | $13.30M | $14.20M | $14.60M |
General and Administrative Expenses | $91.80M | $95.00M | $121.50M | $91.30M | $101.00M | $93.10M | $93.40M | $97.50M | $107.20M | $96.90M | $101.30M | $92.70M | $98.20M | $95.70M | $105.20M | $96.30M | $112.40M | $103.30M | $107.50M | $110.10M |
Selling and Marketing Expenses | $59.60M | $41.10M | $47.00M | $67.50M | $60.60M | $41.20M | $68.40M | $81.90M | $50.00M | $46.20M | $69.90M | $80.90M | $41.30M | $45.90M | $62.90M | $80.00M | $40.30M | $48.20M | $63.10M | $76.60M |
Selling General and Administrative Expenses | $151.40M | $136.10M | $168.50M | $158.80M | $161.60M | $134.30M | $161.80M | $179.40M | $157.20M | $143.10M | $171.20M | $173.60M | $139.50M | $141.60M | $168.10M | $176.30M | $152.70M | $151.50M | $170.60M | $185.90M |
Other Expenses | $-200.00K | $1.60M | $-10.90M | $3.50M | $400.00K | $1.00M | $- | $-800.00K | $1.00M | $1.70M | $3.40M | $4.40M | $3.70M | $5.00M | $-9.50M | $3.80M | $-100.00K | $-300.00K | $-2.70M | $-1.40M |
Operating Expenses | $165.40M | $149.90M | $182.40M | $171.20M | $176.80M | $148.00M | $176.10M | $194.00M | $172.40M | $155.90M | $184.90M | $187.20M | $154.90M | $155.00M | $182.50M | $191.10M | $168.60M | $164.80M | $184.80M | $200.50M |
Cost and Expenses | $463.40M | $410.80M | $462.40M | $432.40M | $443.50M | $405.80M | $453.70M | $497.40M | $470.80M | $429.30M | $502.50M | $570.40M | $473.00M | $435.10M | $539.20M | $561.40M | $474.70M | $456.00M | $526.10M | $561.20M |
Interest Income | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $18.10M | $19.90M | $20.70M | $19.20M | $18.70M | $- | $- | $- |
Interest Expense | $14.60M | $14.30M | $13.90M | $15.50M | $17.50M | $17.40M | $17.30M | $16.40M | $16.80M | $17.30M | $18.00M | $18.00M | $18.10M | $19.90M | $20.70M | $19.20M | $18.70M | $19.80M | $20.40M | $18.80M |
Depreciation and Amortization | $24.60M | $22.50M | $22.00M | $21.00M | $23.30M | $22.20M | $22.20M | $21.50M | $21.20M | $21.40M | $23.20M | $22.50M | $22.80M | $22.50M | $23.10M | $22.50M | $23.20M | $22.50M | $22.40M | $21.70M |
EBITDA | $64.40M | $67.30M | $71.70M | $76.00M | $45.70M | $68.50M | $87.80M | $97.00M | $73.40M | $57.10M | $71.80M | $80.30M | $67.60M | $61.50M | $72.80M | $114.90M | $82.60M | $55.10M | $93.00M | $108.30M |
EBITDA Ratio | 12.20% | 14.82% | 13.71% | 15.71% | 9.35% | 15.19% | 16.91% | 16.91% | 13.51% | 12.32% | 13.11% | 12.87% | 12.59% | 13.11% | 12.17% | 17.68% | 15.47% | 11.27% | 15.52% | 16.72% |
Operating Income | $64.60M | $43.20M | $60.60M | $51.50M | $45.30M | $41.60M | $62.90M | $71.10M | $63.20M | $31.80M | $41.70M | $49.90M | $44.80M | $31.30M | $56.20M | $85.60M | $51.50M | $26.10M | $70.10M | $86.60M |
Operating Income Ratio | 12.23% | 9.52% | 11.59% | 10.64% | 9.27% | 9.22% | 12.11% | 12.39% | 11.63% | 6.86% | 7.61% | 8.00% | 8.34% | 6.67% | 9.39% | 13.17% | 9.64% | 5.34% | 11.70% | 13.37% |
Total Other Income Expenses Net | $-8.90M | $700.00K | $-18.50M | $-30.70M | $-3.60M | $-2.70M | $-28.80M | $-6.00M | $-8.20M | $-500.00K | $-14.60M | $-13.60M | $-1.40M | $-14.90M | $-30.20M | $800.00K | $-8.00M | $-7.10M | $-5.90M | $-24.10M |
Income Before Tax | $41.10M | $29.60M | $28.20M | $5.30M | $24.20M | $25.20M | $19.50M | $53.90M | $47.40M | $16.20M | $27.10M | $36.30M | $43.40M | $16.40M | $26.00M | $70.20M | $32.70M | $6.00M | $47.00M | $62.50M |
Income Before Tax Ratio | 7.78% | 6.52% | 5.39% | 1.10% | 4.95% | 5.59% | 3.76% | 9.40% | 8.73% | 3.50% | 4.95% | 5.82% | 8.08% | 3.50% | 4.34% | 10.80% | 6.12% | 1.23% | 7.84% | 9.65% |
Income Tax Expense | $400.00K | $7.20M | $8.70M | $600.00K | $3.20M | $7.50M | $5.10M | $13.10M | $3.30M | $5.00M | $3.90M | $5.80M | $9.70M | $4.50M | $7.00M | $17.70M | $3.20M | $1.20M | $11.00M | $13.50M |
Net Income | $40.70M | $22.40M | $19.50M | $4.70M | $21.00M | $17.70M | $14.40M | $40.80M | $44.10M | $11.20M | $23.20M | $30.50M | $33.70M | $12.40M | $19.40M | $53.00M | $31.30M | $4.80M | $36.00M | $49.00M |
Net Income Ratio | 7.71% | 4.93% | 3.73% | 0.97% | 4.30% | 3.92% | 2.77% | 7.11% | 8.12% | 2.42% | 4.24% | 4.89% | 6.28% | 2.64% | 3.24% | 8.15% | 5.86% | 0.98% | 6.01% | 7.56% |
EPS | $0.75 | $0.41 | $0.36 | $0.09 | $0.39 | $0.33 | $0.26 | $0.75 | $0.81 | $0.21 | $0.43 | $0.58 | $0.65 | $0.23 | $0.37 | $1.03 | $0.58 | $0.10 | $0.72 | $0.99 |
EPS Diluted | $0.75 | $0.41 | $0.36 | $0.09 | $0.38 | $0.32 | $0.26 | $0.74 | $0.80 | $0.20 | $0.43 | $0.57 | $0.64 | $0.23 | $0.37 | $1.01 | $0.57 | $0.10 | $0.72 | $0.98 |
Weighted Average Shares Outstanding | 54.20M | 54.30M | 54.30M | 54.30M | 54.40M | 54.40M | 54.30M | 54.40M | 54.40M | 54.40M | 53.60M | 52.50M | 51.80M | 51.60M | 51.40M | 51.10M | 50.60M | 50.10M | 49.80M | 49.50M |
Weighted Average Shares Outstanding Diluted | 54.30M | 54.40M | 54.50M | 54.60M | 54.80M | 54.80M | 54.90M | 55.40M | 55.40M | 55.00M | 54.30M | 53.10M | 52.50M | 51.90M | 52.00M | 51.80M | 51.30M | 50.50M | 50.20M | 50.10M |
SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
Breakdown | 2019-09-30 | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 |
---|---|---|---|---|---|
Cash and Cash Equivalents | $341.60M | $364.70M | $479.20M | $188.70M | $216.40M |
Short Term Investments | $- | $- | $- | $- | $- |
Cash and Short Term Investments | $341.60M | $364.70M | $479.20M | $188.70M | $216.40M |
Net Receivables | $205.60M | $158.80M | $150.70M | $136.90M | $106.20M |
Inventory | $357.20M | $314.10M | $345.70M | $449.30M | $492.40M |
Other Current Assets | $140.00M | $146.00M | $160.10M | $167.30M | $147.40M |
Total Current Assets | $1.04B | $983.60M | $1.14B | $942.20M | $962.40M |
Property Plant Equipment Net | $396.00M | $370.90M | $362.60M | $345.50M | $337.90M |
Goodwill | $1.05B | $1.16B | $1.16B | $1.32B | $1.33B |
Intangible Assets | $912.90M | $928.10M | $906.40M | $996.60M | $973.80M |
Goodwill and Intangible Assets | $1.97B | $2.09B | $2.07B | $2.32B | $2.31B |
Long Term Investments | $-101.10M | $-102.50M | $-129.00M | $- | $-136.40M |
Tax Assets | $101.10M | $102.50M | $129.00M | $140.40M | $136.40M |
Other Non-Current Assets | $34.80M | $98.60M | $107.10M | $-33.80M | $135.20M |
Total Non-Current Assets | $2.40B | $2.56B | $2.54B | $2.77B | $2.78B |
Other Assets | $- | $- | $- | $- | $- |
Total Assets | $3.44B | $3.54B | $3.67B | $3.71B | $3.74B |
Account Payables | $222.80M | $181.90M | $209.50M | $237.30M | $205.30M |
Short Term Debt | $131.40M | $21.10M | $26.50M | $19.00M | $19.50M |
Tax Payables | $15.10M | $20.20M | $14.40M | $23.90M | $11.90M |
Deferred Revenue | $1.70M | $1.40M | $600.00K | $1.10M | $600.00K |
Other Current Liabilities | $303.70M | $306.10M | $300.20M | $290.60M | $308.30M |
Total Current Liabilities | $659.60M | $510.50M | $536.80M | $548.00M | $533.70M |
Long Term Debt | $1.10B | $1.24B | $1.23B | $1.39B | $1.36B |
Deferred Revenue Non-Current | $- | $- | $- | $- | $- |
Deferred Tax Liabilities Non-Current | $102.80M | $102.50M | $129.00M | $140.40M | $136.40M |
Other Non-Current Liabilities | $258.90M | $257.10M | $190.30M | $173.60M | $178.60M |
Total Non-Current Liabilities | $1.46B | $1.60B | $1.55B | $1.71B | $1.68B |
Other Liabilities | $- | $- | $- | $- | $- |
Total Liabilities | $2.12B | $2.11B | $2.09B | $2.25B | $2.21B |
Preferred Stock | $- | $- | $- | $- | $- |
Common Stock | $700.00K | $700.00K | $700.00K | $700.00K | $700.00K |
Retained Earnings | $734.10M | $782.40M | $865.70M | $931.70M | $1.01B |
Accumulated Other Comprehensive Income Loss | $-235.90M | $-191.60M | $-136.90M | $-216.10M | $-170.00M |
Other Total Stockholders Equity | $823.90M | $841.40M | $854.80M | $743.40M | $687.70M |
Total Stockholders Equity | $1.32B | $1.43B | $1.58B | $1.46B | $1.53B |
Total Equity | $1.32B | $1.43B | $1.58B | $1.46B | $1.53B |
Total Liabilities and Stockholders Equity | $3.44B | $3.54B | $3.67B | $3.71B | $3.74B |
Minority Interest | $- | $- | $- | $- | $- |
Total Liabilities and Total Equity | $3.44B | $3.54B | $3.67B | $3.71B | $3.74B |
Total Investments | $-101.10M | $-102.50M | $-129.00M | $- | $-136.40M |
Total Debt | $1.23B | $1.26B | $1.26B | $1.41B | $1.38B |
Net Debt | $887.60M | $894.30M | $781.50M | $1.22B | $1.16B |
Quarterly Balance Sheet
Breakdown | 2019-09-30 | 2019-12-31 | 2020-03-31 | 2020-06-30 | 2020-09-30 | 2020-12-31 | 2021-03-31 | 2021-06-30 | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash and Cash Equivalents | $341.60M | $251.80M | $308.80M | $511.90M | $364.70M | $280.80M | $282.10M | $437.50M | $479.20M | $239.80M | $188.10M | $181.60M | $188.70M | $184.10M | $155.20M | $207.40M | $216.40M | $214.20M | $196.20M | $196.10M |
Short Term Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Cash and Short Term Investments | $341.60M | $251.80M | $308.80M | $511.90M | $364.70M | $280.80M | $282.10M | $437.50M | $479.20M | $239.80M | $188.10M | $181.60M | $188.70M | $184.10M | $155.20M | $207.40M | $216.40M | $214.20M | $196.20M | $196.10M |
Net Receivables | $205.60M | $242.50M | $259.80M | $238.00M | $158.80M | $167.00M | $269.60M | $221.60M | $150.70M | $233.40M | $264.90M | $247.90M | $136.90M | $123.10M | $160.80M | $121.50M | $106.20M | $177.40M | $209.30M | $216.20M |
Inventory | $357.20M | $367.00M | $340.10M | $323.50M | $314.10M | $337.00M | $354.20M | $359.20M | $345.70M | $407.50M | $429.10M | $414.10M | $449.30M | $540.20M | $540.50M | $502.50M | $492.40M | $521.90M | $496.40M | $455.90M |
Other Current Assets | $140.00M | $17.20M | $12.60M | $10.40M | $146.00M | $148.60M | $11.00M | $11.40M | $160.10M | $8.40M | $9.10M | $16.30M | $167.30M | $160.10M | $152.70M | $157.20M | $147.40M | $9.50M | $14.10M | $90.50M |
Total Current Assets | $1.04B | $946.60M | $989.20M | $1.15B | $983.60M | $933.40M | $987.70M | $1.10B | $1.14B | $966.90M | $968.70M | $933.70M | $942.20M | $1.01B | $1.01B | $988.60M | $962.40M | $1.01B | $994.80M | $958.70M |
Property Plant Equipment Net | $396.00M | $384.80M | $372.00M | $366.30M | $370.90M | $368.90M | $360.90M | $358.10M | $362.60M | $356.60M | $355.40M | $347.80M | $345.50M | $348.60M | $342.30M | $339.80M | $337.90M | $333.50M | $327.50M | $325.40M |
Goodwill | $1.05B | $1.03B | $1.02B | $1.03B | $1.16B | $1.17B | $1.16B | $1.17B | $1.16B | $1.34B | $1.34B | $1.33B | $1.32B | $1.33B | $1.33B | $1.34B | $1.33B | $1.34B | $1.33B | $1.33B |
Intangible Assets | $912.90M | $843.80M | $836.20M | $833.40M | $928.10M | $927.50M | $918.90M | $914.40M | $906.40M | $1.03B | $1.02B | $1.01B | $996.60M | $996.80M | $990.10M | $983.70M | $973.80M | $970.10M | $960.40M | $952.20M |
Goodwill and Intangible Assets | $1.97B | $1.87B | $1.86B | $1.86B | $2.09B | $2.10B | $2.08B | $2.08B | $2.07B | $2.38B | $2.36B | $2.34B | $2.32B | $2.33B | $2.32B | $2.32B | $2.31B | $2.31B | $2.29B | $2.29B |
Long Term Investments | $- | $-84.00M | $- | $-83.10M | $- | $-103.90M | $- | $-103.40M | $- | $-150.10M | $-139.10M | $- | $- | $- | $- | $-142.30M | $-136.40M | $-136.90M | $-136.10M | $-137.30M |
Tax Assets | $- | $84.00M | $- | $83.10M | $- | $103.90M | $- | $103.40M | $- | $150.10M | $139.10M | $137.80M | $- | $140.90M | $141.60M | $142.30M | $136.40M | $136.90M | $136.10M | $137.30M |
Other Non-Current Assets | $34.80M | $97.30M | $87.50M | $87.60M | $98.60M | $98.60M | $105.50M | $105.80M | $107.10M | $105.90M | $104.40M | $-41.00M | $106.60M | $-29.10M | $-18.20M | $118.10M | $135.20M | $141.00M | $139.70M | $138.90M |
Total Non-Current Assets | $2.40B | $2.36B | $2.32B | $2.31B | $2.56B | $2.56B | $2.55B | $2.55B | $2.54B | $2.84B | $2.82B | $2.79B | $2.77B | $2.79B | $2.79B | $2.78B | $2.78B | $2.78B | $2.76B | $2.75B |
Other Assets | $- | $-100.00K | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Assets | $3.44B | $3.30B | $3.31B | $3.47B | $3.54B | $3.50B | $3.54B | $3.65B | $3.67B | $3.81B | $3.79B | $3.72B | $3.71B | $3.80B | $3.80B | $3.77B | $3.74B | $3.79B | $3.76B | $3.71B |
Account Payables | $222.80M | $195.10M | $190.30M | $181.50M | $181.90M | $182.70M | $194.00M | $215.90M | $209.50M | $217.80M | $224.70M | $239.20M | $237.30M | $245.00M | $245.10M | $241.10M | $205.30M | $197.50M | $219.70M | $208.70M |
Short Term Debt | $131.40M | $29.00M | $28.50M | $28.20M | $21.10M | $24.10M | $35.10M | $35.50M | $26.50M | $39.00M | $37.00M | $29.30M | $19.00M | $25.20M | $21.50M | $17.70M | $19.50M | $24.20M | $23.60M | $21.40M |
Tax Payables | $15.10M | $22.60M | $22.90M | $19.50M | $20.20M | $7.20M | $12.00M | $21.80M | $14.40M | $13.00M | $18.10M | $20.70M | $23.90M | $13.90M | $- | $- | $11.90M | $6.50M | $35.10M | $18.20M |
Deferred Revenue | $101.10M | $1.50M | $1.90M | $1.40M | $1.40M | $700.00K | $2.00M | $3.40M | $600.00K | $2.30M | $2.10M | $1.10M | $1.10M | $1.00M | $- | $- | $600.00K | $151.70M | $209.70M | $18.20M |
Other Current Liabilities | $204.30M | $236.90M | $265.50M | $273.30M | $306.10M | $221.40M | $252.70M | $292.30M | $300.20M | $224.80M | $280.40M | $305.50M | $290.60M | $230.10M | $302.40M | $321.00M | $308.30M | $94.30M | $88.90M | $286.80M |
Total Current Liabilities | $659.60M | $462.50M | $486.20M | $484.40M | $510.50M | $428.90M | $483.80M | $547.10M | $536.80M | $483.90M | $544.20M | $575.10M | $548.00M | $501.30M | $569.00M | $579.80M | $533.70M | $467.70M | $541.90M | $535.10M |
Long Term Debt | $1.10B | $1.14B | $1.14B | $1.27B | $1.24B | $1.24B | $1.28B | $1.28B | $1.23B | $1.48B | $1.46B | $1.40B | $1.39B | $1.49B | $1.41B | $1.32B | $1.36B | $1.45B | $1.35B | $1.29B |
Deferred Revenue Non-Current | $- | $182.80M | $172.60M | $175.00M | $- | $- | $141.80M | $141.60M | $- | $150.00M | $- | $- | $- | $- | $- | $- | $- | $59.60M | $60.70M | $- |
Deferred Tax Liabilities Non-Current | $102.80M | $84.00M | $84.70M | $83.10M | $102.50M | $103.90M | $103.50M | $103.40M | $129.00M | $150.10M | $139.10M | $137.80M | $140.40M | $140.90M | $141.60M | $142.30M | $136.40M | $136.90M | $136.10M | $137.30M |
Other Non-Current Liabilities | $258.90M | $84.10M | $81.00M | $82.20M | $257.10M | $259.70M | $68.30M | $67.50M | $190.30M | $-6.80M | $135.80M | $132.50M | $173.60M | $176.10M | $167.40M | $170.00M | $178.60M | $124.90M | $115.50M | $169.00M |
Total Non-Current Liabilities | $1.46B | $1.49B | $1.48B | $1.61B | $1.60B | $1.60B | $1.59B | $1.59B | $1.55B | $1.77B | $1.73B | $1.67B | $1.71B | $1.81B | $1.72B | $1.64B | $1.68B | $1.77B | $1.66B | $1.60B |
Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Liabilities | $2.12B | $1.96B | $1.96B | $2.10B | $2.11B | $2.03B | $2.07B | $2.14B | $2.09B | $2.25B | $2.28B | $2.24B | $2.25B | $2.31B | $2.29B | $2.22B | $2.21B | $2.24B | $2.21B | $2.13B |
Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $- | $200.00K | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Common Stock | $700.00K | $700.00K | $700.00K | $700.00K | $700.00K | $700.00K | $700.00K | $700.00K | $700.00K | $700.00K | $700.00K | $700.00K | $700.00K | $700.00K | $700.00K | $700.00K | $700.00K | $700.00K | $700.00K | $700.00K |
Retained Earnings | $734.10M | $737.20M | $756.70M | $761.40M | $782.40M | $791.60M | $797.70M | $829.90M | $865.70M | $868.50M | $883.50M | $905.90M | $931.70M | $935.60M | $946.40M | $991.20M | $1.01B | $1.02B | $1.05B | $1.09B |
Accumulated Other Comprehensive Income Loss | $-235.90M | $-217.20M | $-242.70M | $-231.10M | $-191.60M | $-161.70M | $-175.00M | $-166.40M | $-136.90M | $-143.40M | $-151.30M | $-181.90M | $-216.10M | $-176.50M | $-159.70M | $-150.80M | $-170.00M | $-146.50M | $-160.30M | $-173.30M |
Other Total Stockholders Equity | $823.90M | $827.40M | $832.60M | $837.20M | $841.40M | $834.60M | $840.70M | $847.40M | $854.80M | $826.30M | $782.60M | $753.40M | $743.40M | $726.90M | $719.60M | $710.00M | $687.70M | $672.30M | $663.20M | $660.20M |
Total Stockholders Equity | $1.32B | $1.35B | $1.35B | $1.37B | $1.43B | $1.47B | $1.46B | $1.51B | $1.58B | $1.55B | $1.52B | $1.48B | $1.46B | $1.49B | $1.51B | $1.55B | $1.53B | $1.55B | $1.55B | $1.58B |
Total Equity | $1.32B | $1.35B | $1.35B | $1.37B | $1.43B | $1.47B | $1.46B | $1.51B | $1.58B | $1.55B | $1.52B | $1.48B | $1.46B | $1.49B | $1.51B | $1.55B | $1.53B | $1.55B | $1.55B | $1.58B |
Total Liabilities and Stockholders Equity | $3.44B | $3.30B | $3.31B | $3.47B | $3.54B | $3.50B | $3.54B | $3.65B | $3.67B | $3.81B | $3.79B | $3.72B | $3.71B | $3.80B | $3.80B | $3.77B | $3.74B | $3.79B | $3.76B | $3.71B |
Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Liabilities and Total Equity | $3.44B | $3.30B | $3.31B | $3.47B | $3.54B | $3.50B | $3.54B | $3.65B | $3.67B | $3.81B | $3.79B | $3.72B | $3.71B | $3.80B | $3.80B | $3.77B | $3.74B | $3.79B | $3.76B | $3.71B |
Total Investments | $- | $-84.00M | $- | $-83.10M | $- | $-103.90M | $- | $-103.40M | $- | $-150.10M | $-139.10M | $- | $- | $- | $- | $-142.30M | $-136.40M | $-136.90M | $-136.10M | $-137.30M |
Total Debt | $1.23B | $1.17B | $1.17B | $1.30B | $1.26B | $1.26B | $1.31B | $1.31B | $1.26B | $1.52B | $1.50B | $1.43B | $1.41B | $1.52B | $1.44B | $1.34B | $1.38B | $1.48B | $1.37B | $1.31B |
Net Debt | $887.60M | $918.90M | $856.40M | $789.00M | $894.30M | $981.70M | $1.03B | $874.00M | $781.50M | $1.28B | $1.31B | $1.25B | $1.22B | $1.33B | $1.28B | $1.13B | $1.16B | $1.26B | $1.18B | $1.12B |
Annual Cash Flow Statement
Breakdown | 2019-09-30 | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 |
---|---|---|---|---|---|
Net Income | $-352.90M | $67.60M | $117.00M | $98.60M | $112.90M |
Depreciation and Amortization | $93.80M | $88.80M | $87.10M | $89.90M | $91.40M |
Deferred Income Tax | $-57.90M | $-2.90M | $9.60M | $-13.70M | $-4.50M |
Stock Based Compensation | $17.80M | $19.20M | $27.30M | $23.80M | $27.50M |
Change in Working Capital | $-47.50M | $43.20M | $-26.90M | $-81.00M | $6.80M |
Accounts Receivables | $-1.90M | $66.30M | $3.70M | $-6.60M | $2.70M |
Inventory | $-35.00M | $37.10M | $-28.80M | $-111.30M | $-32.40M |
Accounts Payables | $-15.10M | $-42.90M | $25.40M | $30.40M | $-30.20M |
Other Working Capital | $4.50M | $-17.30M | $-27.20M | $6.50M | $66.70M |
Other Non Cash Items | $537.30M | $16.70M | $14.90M | $-15.60M | $-18.00M |
Net Cash Provided by Operating Activities | $190.60M | $232.60M | $229.00M | $102.00M | $216.10M |
Investments in Property Plant and Equipment | $-58.00M | $-47.70M | $-56.80M | $-56.40M | $-49.50M |
Acquisitions Net | $4.10M | $-137.80M | $7.20M | $-304.40M | $- |
Purchases of Investments | $- | $-13.80M | $- | $- | $- |
Sales Maturities of Investments | $- | $47.70M | $- | $- | $- |
Other Investing Activities | $8.40M | $-44.80M | $900.00K | $5.40M | $-1.00M |
Net Cash Used for Investing Activities | $-45.50M | $-196.40M | $-48.70M | $-355.40M | $-50.50M |
Debt Repayment | $-509.00M | $-767.00M | $-2.30M | $-552.00M | $-874.00M |
Common Stock Issued | $- | $750.00M | $- | $- | $841.00M |
Common Stock Repurchased | $-3.00M | $-2.00M | $-13.40M | $-125.30M | $-75.20M |
Dividends Paid | $- | $- | $-25.60M | $-32.60M | $-31.50M |
Other Financing Activities | $448.20M | $2.30M | $-26.40M | $692.30M | $-6.80M |
Net Cash Used Provided by Financing Activities | $-63.80M | $-18.70M | $-65.40M | $-17.60M | $-146.50M |
Effect of Forex Changes on Cash | $-6.10M | $5.60M | $-400.00K | $-19.50M | $8.60M |
Net Change in Cash | $75.20M | $23.10M | $114.50M | $-290.50M | $27.70M |
Cash at End of Period | $341.60M | $364.70M | $479.20M | $188.70M | $216.40M |
Cash at Beginning of Period | $266.40M | $341.60M | $364.70M | $479.20M | $188.70M |
Operating Cash Flow | $190.60M | $232.60M | $229.00M | $102.00M | $216.10M |
Capital Expenditure | $-58.00M | $-47.70M | $-56.80M | $-56.40M | $-49.50M |
Free Cash Flow | $132.60M | $184.90M | $172.20M | $45.60M | $166.60M |
Quarterly Cash Flow Statement
Breakdown | 2019-09-30 | 2019-12-31 | 2020-03-31 | 2020-06-30 | 2020-09-30 | 2020-12-31 | 2021-03-31 | 2021-06-30 | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | $21.40M | $22.40M | $19.50M | $4.70M | $21.00M | $17.70M | $14.40M | $40.80M | $44.10M | $11.20M | $23.20M | $30.50M | $33.70M | $11.90M | $19.00M | $52.50M | $29.50M | $4.80M | $36.00M | $49.00M |
Depreciation and Amortization | $24.60M | $22.50M | $22.00M | $21.00M | $23.30M | $22.20M | $22.20M | $21.50M | $21.20M | $21.40M | $23.20M | $22.50M | $22.80M | $22.50M | $23.10M | $22.50M | $23.30M | $22.50M | $22.40M | $21.70M |
Deferred Income Tax | $-2.80M | $-16.70M | $1.20M | $-600.00K | $13.20M | $200.00K | $-800.00K | $-500.00K | $10.90M | $-100.00K | $-10.40M | $-100.00K | $-3.10M | $-100.00K | $-800.00K | $300.00K | $-3.90M | $-200.00K | $-400.00K | $1.90M |
Stock Based Compensation | $4.00M | $4.90M | $5.30M | $4.90M | $4.10M | $5.30M | $6.70M | $7.60M | $7.70M | $5.50M | $6.70M | $6.20M | $5.40M | $6.50M | $6.80M | $6.50M | $7.70M | $7.00M | $6.30M | $7.10M |
Change in Working Capital | $29.70M | $-78.50M | $18.20M | $45.90M | $57.60M | $-128.70M | $6.10M | $104.70M | $-9.00M | $-118.50M | $5.50M | $56.90M | $-24.90M | $-126.00M | $54.90M | $78.90M | $-1.00M | $-106.10M | $70.00M | $27.60M |
Accounts Receivables | $-1.90M | $2.80M | $- | $- | $-1.90M | $1.00M | $- | $- | $2.70M | $-1.00M | $- | $6.60M | $-1.90M | $400.00K | $- | $- | $30.60M | $4.80M | $- | $- |
Inventory | $-35.00M | $- | $- | $- | $-35.00M | $- | $- | $- | $-28.80M | $- | $- | $- | $-28.80M | $- | $- | $- | $-32.40M | $- | $- | $- |
Accounts Payables | $-15.10M | $- | $- | $- | $-15.10M | $- | $- | $- | $25.40M | $- | $- | $- | $25.40M | $- | $- | $- | $-30.20M | $- | $- | $- |
Other Working Capital | $81.70M | $-81.30M | $18.20M | $45.90M | $109.60M | $-129.70M | $6.10M | $104.70M | $-8.30M | $-117.50M | $5.50M | $50.30M | $-19.60M | $-126.40M | $54.90M | $78.90M | $31.00M | $-110.90M | $70.00M | $27.60M |
Other Non Cash Items | $15.50M | $-1.50M | $-2.10M | $25.50M | $-5.20M | $800.00K | $15.10M | $600.00K | $-1.80M | $1.50M | $-9.10M | $-3.70M | $-4.30M | $-1.10M | $-14.80M | $5.70M | $-7.80M | $-900.00K | $-5.40M | $44.40M |
Net Cash Provided by Operating Activities | $92.40M | $-46.90M | $64.10M | $101.40M | $114.00M | $-82.50M | $63.70M | $174.70M | $73.10M | $-79.00M | $39.10M | $112.30M | $29.60M | $-86.30M | $88.20M | $166.40M | $47.80M | $-72.90M | $129.00M | $101.20M |
Investments in Property Plant and Equipment | $-19.30M | $-7.60M | $-9.20M | $-10.10M | $-20.80M | $-10.20M | $-12.00M | $-11.90M | $-22.70M | $-9.40M | $-15.60M | $-12.40M | $-19.00M | $-11.30M | $-7.50M | $-12.30M | $-18.40M | $-6.50M | $-11.50M | $-12.60M |
Acquisitions Net | $- | $95.80M | $- | $- | $-233.60M | $7.20M | $- | $- | $-7.50M | $-303.80M | $-600.00K | $4.20M | $304.10M | $- | $-2.00M | $- | $2.00M | $- | $- | $- |
Purchases of Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Sales Maturities of Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Other Investing Activities | $700.00K | $1.50M | $600.00K | $300.00K | $-13.30M | $700.00K | $700.00K | $-600.00K | $7.60M | $500.00K | $3.20M | $-3.70M | $-302.90M | $100.00K | $700.00K | $700.00K | $-2.50M | $500.00K | $-2.20M | $-4.60M |
Net Cash Used for Investing Activities | $-18.60M | $89.70M | $-8.60M | $-9.80M | $-267.70M | $-2.30M | $-11.30M | $-12.50M | $-22.60M | $-312.70M | $-13.00M | $-11.90M | $-17.80M | $-11.20M | $-8.80M | $-11.60M | $-18.90M | $-6.00M | $-13.70M | $-17.20M |
Debt Repayment | $-126.00M | $-167.10M | $-100.00K | $-600.00M | $-767.00M | $- | $-7.70M | $-1.10M | $-1.80M | $-199.40M | $-19.70M | $-193.00M | $-139.00M | $-141.00M | $-252.40M | $-321.60M | $-159.00M | $-125.00M | $-102.20M | $-63.00M |
Common Stock Issued | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $237.10M | $190.90M | $220.10M | $- | $- |
Common Stock Repurchased | $-1.20M | $-1.50M | $- | $-200.00K | $-300.00K | $-12.20M | $- | $-1.00M | $-200.00K | $-24.50M | $-50.90M | $-34.70M | $-15.20M | $-15.00M | $-15.00M | $-15.20M | $-30.00M | $-15.00M | $-15.30M | $-9.90M |
Dividends Paid | $- | $- | $- | $- | $- | $- | $-8.40M | $-8.30M | $-8.90M | $-8.50M | $-8.20M | $-8.00M | $-7.90M | $-8.30M | $-7.80M | $-7.70M | $-7.70M | $-7.60M | $-8.20M | $-7.50M |
Other Financing Activities | $119.70M | $31.20M | $5.50M | $708.90M | $769.90M | $6.70M | $-38.20M | $1.50M | $3.60M | $188.50M | $-18.10M | $136.00M | $165.90M | $247.20M | $163.30M | $4.10M | $-8.40M | $-2.70M | $-3.50M | $500.00K |
Net Cash Used Provided by Financing Activities | $-6.30M | $-135.90M | $5.40M | $108.90M | $2.90M | $-5.50M | $-46.60M | $-7.80M | $-5.50M | $155.50M | $-77.20M | $-99.70M | $3.80M | $82.90M | $-111.90M | $-103.30M | $-14.20M | $69.80M | $-129.20M | $-79.90M |
Effect of Forex Changes on Cash | $-4.90M | $3.30M | $-3.90M | $2.60M | $3.60M | $6.40M | $-4.50M | $1.00M | $-3.30M | $-3.20M | $-600.00K | $-7.20M | $-8.50M | $10.00M | $3.60M | $700.00K | $-5.70M | $6.90M | $-4.10M | $-4.20M |
Net Change in Cash | $62.60M | $-89.80M | $57.00M | $203.10M | $-147.20M | $-83.90M | $1.30M | $155.40M | $41.70M | $-239.40M | $-51.70M | $-6.50M | $7.10M | $-4.60M | $-28.90M | $52.20M | $9.00M | $-2.20M | $-18.00M | $-100.00K |
Cash at End of Period | $341.60M | $251.80M | $308.80M | $511.90M | $364.70M | $280.80M | $282.10M | $437.50M | $479.20M | $239.80M | $188.10M | $181.60M | $188.70M | $184.10M | $155.20M | $207.40M | $216.40M | $214.20M | $196.20M | $196.10M |
Cash at Beginning of Period | $279.00M | $341.60M | $251.80M | $308.80M | $511.90M | $364.70M | $280.80M | $282.10M | $437.50M | $479.20M | $239.80M | $188.10M | $181.60M | $188.70M | $184.10M | $155.20M | $207.40M | $216.40M | $214.20M | $196.20M |
Operating Cash Flow | $92.40M | $-46.90M | $64.10M | $101.40M | $114.00M | $-82.50M | $63.70M | $174.70M | $73.10M | $-79.00M | $39.10M | $112.30M | $29.60M | $-86.30M | $88.20M | $166.40M | $47.80M | $-72.90M | $129.00M | $101.20M |
Capital Expenditure | $-19.30M | $-7.60M | $-9.20M | $-10.10M | $-20.80M | $-10.20M | $-12.00M | $-11.90M | $-22.70M | $-9.40M | $-15.60M | $-12.40M | $-19.00M | $-11.30M | $-7.50M | $-12.30M | $-18.40M | $-6.50M | $-11.50M | $-12.60M |
Free Cash Flow | $73.10M | $-54.50M | $54.90M | $91.30M | $93.20M | $-92.70M | $51.70M | $162.80M | $50.40M | $-88.40M | $23.50M | $99.90M | $10.60M | $-97.60M | $80.70M | $154.10M | $29.40M | $-79.40M | $117.50M | $88.60M |
Edgewell Personal Care Dividends
Understand Edgewell Personal Care's dividend history, dividend yield, payout ratio, and more.
Dividend Yield
1.66%
Dividend Payout Ratio
27.46%
Dividend Paid & Capex Coverage Ratio
-12.01x
Edgewell Personal Care Dividend History
Dividend | Adjusted Dividend | Date | Record Date | Payment Date | Declaration Date |
---|---|---|---|---|---|
$0.15 | $0.15 | September 04, 2024 | September 04, 2024 | October 03, 2024 | August 06, 2024 |
$0.15 | $0.15 | June 06, 2024 | June 06, 2024 | July 09, 2024 | May 08, 2024 |
$0.15 | $0.15 | March 06, 2024 | March 07, 2024 | April 04, 2024 | February 01, 2024 |
$0.15 | $0.15 | December 05, 2023 | December 06, 2023 | January 04, 2024 | November 02, 2023 |
$0.15 | $0.15 | September 06, 2023 | September 07, 2023 | October 04, 2023 | August 01, 2023 |
$0.15 | $0.15 | June 06, 2023 | June 07, 2023 | July 06, 2023 | May 09, 2023 |
$0.15 | $0.15 | March 07, 2023 | March 08, 2023 | April 05, 2023 | February 03, 2023 |
$0.15 | $0.15 | November 28, 2022 | November 29, 2022 | January 04, 2023 | November 03, 2022 |
$0.15 | $0.15 | September 01, 2022 | September 02, 2022 | October 05, 2022 | July 29, 2022 |
$0.15 | $0.15 | June 01, 2022 | June 02, 2022 | July 07, 2022 | May 06, 2022 |
$0.15 | $0.15 | March 07, 2022 | March 08, 2022 | April 05, 2022 | February 08, 2022 |
$0.15 | $0.15 | December 02, 2021 | December 03, 2021 | January 06, 2022 | November 04, 2021 |
$0.15 | $0.15 | September 08, 2021 | September 09, 2021 | October 05, 2021 | August 05, 2021 |
$0.15 | $0.15 | June 03, 2021 | June 04, 2021 | July 07, 2021 | May 06, 2021 |
$0.15 | $0.15 | March 04, 2021 | March 05, 2021 | April 06, 2021 | February 09, 2021 |
$0.15 | $0.15 | December 09, 2020 | December 10, 2020 | January 06, 2021 | November 20, 2020 |
$0.25 | $0.25 | August 17, 2015 | August 19, 2015 | September 09, 2015 | July 02, 2015 |
$0.5 | $0.37065 | May 18, 2015 | May 20, 2015 | June 10, 2015 | April 28, 2015 |
$0.5 | $0.37065 | February 17, 2015 | February 19, 2015 | March 18, 2015 | January 27, 2015 |
$0.5 | $0.37065 | November 17, 2014 | November 19, 2014 | December 16, 2014 | November 03, 2014 |
Valuation
Analyze the market cap, enterprise value, and valuation metrics for Edgewell Personal Care.
Market Cap & Enterprise Value
Market Cap: $1.70B
Enterprise Value: $3.06B
Valuation Ratios
P/E Ratio: 16.50
P/B Ratio: 1.24
P/CF Ratio: 8.76
Valuation Multiples
E/V to Sales: 1.36
E/V to EBITDA: 9.21
Market Cap & Enterprise Value
Market capitalization and enterprise value provide an understanding of a company's market value and total value, respectively.
- Market Cap: The total market value of a company's outstanding shares of stock. It represents the company's equity value and is calculated by multiplying the current share price by the total number of outstanding shares.
- Enterprise Value (EV): A measure of a company's total value, often seen as a more comprehensive alternative to equity market capitalization. It includes market cap plus debt, minority interest, and preferred shares, minus total cash and cash equivalents.
Valuation Ratios
Valuation ratios are used to evaluate the value of a company compared to its earnings, book value, and cash flow.
- P/E Ratio: Price to Earnings Ratio, indicating how much investors are willing to pay for a dollar of earnings.
- P/B Ratio: Price to Book Ratio, comparing the company's market value to its book value. A lower ratio may indicate undervaluation.
- P/CF Ratio: Price to Cash Flow Ratio, evaluating the market value relative to the operating cash flow. A lower ratio can signal a more attractive investment.
Valuation Multiples
Valuation multiples help assess a company's value relative to its revenue and earnings.
- EV to Sales: Enterprise Value to Sales, comparing the enterprise value to sales revenue. A lower ratio can indicate a more attractive investment.
- EV to EBITDA: Enterprise Value to EBITDA, comparing the enterprise value to earnings before interest, taxes, depreciation, and amortization. A lower ratio suggests a company may be undervalued.
Edgewell Personal Care Growth
View income_statement_chart2_annual_data financial growth metrics for Edgewell Personal Care, including income statement, balance sheet, and cash flow growth.
Income Growth
Revenue Growth: 8.07%
Operating Income Growth: 23.54%
Cash Flow Growth
Net Income Growth: 36.11%
Free Cash Flow Growth: -24.60%
Balance Sheet Growth
Total Assets Growth: -1.28%
Total Liabilities Growth: -3.32%
Income Growth
This section highlights key metrics related to income growth, showing how the company’s revenue and operating income have changed over time:
- Revenue Growth: The increase in a company's sales over time. It is a measure of how quickly the company is growing its revenue. This chart shows the historical trend of revenue growth.
- Operating Income Growth: The growth rate of a company's operating income, which is the income earned from its normal business operations. This chart helps to assess the company's operational efficiency and profitability growth over time.
Cash Flow Growth
This section highlights key metrics on the company's cash flow growth, reflecting changes in net income and free cash flow over time.
- Net Income Growth: The increase in a company's net profit over time. It reflects the company's ability to increase its profitability. This chart provides insight into how the company's bottom line has grown.
- Free Cash Flow Growth: The growth in a company's free cash flow, which is the cash generated by the company after accounting for capital expenditures. This chart is important for understanding the company's financial flexibility and ability to fund operations and growth.
Balance Sheet Growth
This section highlight key metrics related to balance sheet growth, which indicate how the company’s total assets and liabilities have changed over time:
- Total Assets Growth: The rate at which a company's total assets are increasing over time. This chart indicates how the company's asset base is expanding, which can be a sign of growth and investment in future operations.
- Total Liabilities Growth: The rate at which a company's total liabilities are increasing over time. This chart helps to assess the company's financial leverage and risk over time.
Peers: Household & Personal Products
This section provides companies within the same sector, on the same exchange, and of similar market capitalization, allowing comparisons of key financial indicators among peers.
Company | Market Cap | Price | EPS | P/E Ratio | P/B Ratio |
---|---|---|---|---|---|
Mannatech, Incorporated
MTEX
|
$13.85M | $7.35 | $-1.20 | $-6.75 | $1.44 |
Inter Parfums, Inc.
IPAR
|
$3.97B | $123.98 | $4.77 | $30.18 | $6.59 |
Nu Skin Enterprises, Inc.
NUS
|
$315.61M | $6.35 | $0.17 | $112.32 | $1.17 |
Helen of Troy Limited
HELE
|
$1.43B | $62.78 | $7.06 | $17.69 | $1.82 |
|
$- | $ | $ | $ | $ |
European Wax Center, Inc.
EWCZ
|
$335.31M | $7.02 | $0.17 | $74.62 | $8.00 |
Henkel AG & Co. KGaA
HELKF
|
$37.70B | $83.43 | $3.14 | $17.89 | $1.07 |
Natura &Co Holding S.A.
NTCO
|
$4.55B | $6.60 | $-3.60 | $-6.44 | $0.71 |
More metrics for Edgewell Personal Care
Access more key metrics, financials, ratios, and more with the links below.